The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
06-Sep-2012 - Improving efficiency in biopharma research is a “mixed blessing” for contract research organisations (CROs), according to Wells Fargo.
05-Sep-2012 - Outsourcing-Pharma.com presents a round-up of the latest from the world of contract manufacturing, including extensive jobs cuts for Merck, a monoclonal antibody agreement for Cobra and Algeta and Aesica’s latest...
29-Aug-2012 - Charles River Laboratories has acquired Accugenix in a bid to expand its endotoxin and microbial detection portfolio.
28-Aug-2012 - Health economics and outcomes research teams must have a greater influence over clinical trial design if pharma firms are to achieve reimbursement goals, according to Cutting Edge Information.
07-Aug-2012 - Outsourcing-Pharma.com presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and...
01-Aug-2012 - AstraZeneca and Assay Depot have launched a new “virtual research lab” which they say will allow a small group of scientists to run full drug discovery from a laptop....
23-Jul-2012 - SPIC has pressed the Indian PM to issue a standardised excise duty to all contract manufacturers operating in the country so drugsmakers can have a level playing field.
17-Jul-2012 - BioFocus has taken on Titian’s sample management software in a bid to pump more resources into “refreshing” its 900,000 strong high-throughput screening (HTS) compound portfolio.
09-Jul-2012 - No job losses, facility divestitures or strategic changes are planned at DPT Laboratories according to new owner Renaissance Pharma, which bought the CDMO in an out-of-the-blue deal last week.
09-Jul-2012 - iGATE says its new information management platform will provide a 70 per cent decrease in content management costs for the drug development process.
05-Jul-2012 - ‘Merge CDMO and CRO activities to fix the holes in the early phase clinical research industry’, said Quotient Clinical’s CEO Mark Egerton.
03-Jul-2012 - Cutting in-house R&D staff to outsource more activities cuts will drive the industry forward, according to a new report.
28-Jun-2012 - A shortage of staff to serve strategic deals will drive big CROs to scale and consolidate through M&A, an analyst predicts.
27-Jun-2012 - “Collaborate to innovate,” is the message DIA has for clinical researchers at its 2012 Annual Meeting in Philadelphia, US.
25-Jun-2012 - Catalent and Bend Research have joined forces to tackle time and cost restrictions for the complex oral controlled-release development and manufacturing process.
13-Jun-2012 - SAFC has coupled its chiral screening and small-scale purification services to meet what it says is a boom in demand for more complete chemical analysis from drugmakers.
11-Jun-2012 - S&P thinks PRA will use the flexibility in its new credit facility to grow its business through acquisitions.
07-Jun-2012 - inVentiv Health will expand its digital and social media commercial services following the takeover of Kazaam Interactive.
05-Jun-2012 - Outsourcing-Pharma presents a roundup of M&A activity in the CMO space, including Piramal on the hunt for deals and Siegfried buying AMP.
29-May-2012 - Kemwell is set to complete a new biologics manufacturing facility in Bangalore, India, following its long-term partnership with Boehringer Ingelheim.
28-May-2012 - More than a third of patient recruitment will be done in emerging markets in the future, predicts Chiltern CEO Glenn Kerkhof.
21-May-2012 - The CEO of PDI said the contract sales market has “shrunk” over the past few quarters as the flow of business awards has dried up.
09-May-2012 - Increased oversight by the FDA is causing some US-based CMOs to shut down, a speaker at Interphex said.
07-May-2012 - The CEO of Charles River said asset transfer strategic deals make little “rational sense” to clients or CROs.
25-Apr-2012 - The European CMO industry could be blocked by over complex layers of regulation, says Frost & Sullivan analyst Aiswariya Chidambaram.